Insider trading

Period: 12 months Stock: IONS Role: Other officers × Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

21 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

21 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

21 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

21 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
21 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
21 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

21 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Apr 2026
Baroldi Joseph EVP, Chief Business Officer
Sold at will
$418.95K 5,619 at 74.56
10.8%
Not planned
16 Apr 2026
Jenne Kyle EVP, Chf GL Pdt Str Ofcr
Sold at will
$368.49K 4,902 at 75.17
17.1%
Not planned
16 Apr 2026
Birchler Brian EVP, Corp and Development Ops
Sold at will
$73.02K 973 at 75.04
1.4%
Not planned
30 Jan 2026
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold at will
$516.15K 6,179 at 83.53
7.9%
Not planned
30 Jan 2026
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold at will
$515.63K 6,179 at 83.45
8.1%
Not planned
30 Jan 2026
Birchler Brian EVP, Corp and Development Ops
Sold at will
$513.05K 6,179 at 83.03
8.5%
Not planned
30 Jan 2026
Swayze Eric EVP Research
Sold at will
$512.45K 6,179 at 82.93
11.5%
Not planned
30 Jan 2026
BENNETT C FRANK EVP, Chief Scientific Officer
Sold at will
$488.14K 5,885 at 82.95
5.5%
Not planned
30 Jan 2026
Baroldi Joseph EVP, Chief Business Officer
Sold at will
$439.36K 5,296 at 82.96
10.4%
Not planned
16 Jan 2026
Swayze Eric EVP Research
Sold at will
$744.66K 9,884 at 75.34
19.1%
Not planned
16 Jan 2026
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold at will
$703.14K 9,302 at 75.59
12.7%
Not planned
16 Jan 2026
O'NEIL PATRICK R. EVP CLO & General Counsel
Sold at will
$697.05K 9,191 at 75.84
12.2%
Not planned
16 Jan 2026
BENNETT C FRANK EVP, Chief Scientific Officer
Sold at will
$674.62K 8,977 at 75.15
8.7%
Not planned
16 Jan 2026
Birchler Brian EVP, Corp and Development Ops
Sold at will
$636.93K 8,480 at 75.11
12.3%
Not planned
16 Jan 2026
Devers Shannon L. EVP, Chief Human Resources Ofc
Sold at will
$634.41K 8,353 at 75.95
24.0%
Not planned
16 Jan 2026
Baroldi Joseph EVP, Chief Business Officer
Sold at will
$523.21K 6,907 at 75.75
14.6%
Not planned
16 Jan 2026
Kordasiewicz Holly B. EVP, Chief Development Officer
Sold at will
$313.31K 4,141 at 75.66
22.0%
Not planned
16 Jan 2026
Jenne Kyle EVP, Chf GL Pdt Str Ofcr
Sold at will
$138.48K 1,823 at 75.96
10.0%
Not planned
16 Jan 2026
Baroldi Joseph EVP, Chief Business Officer · indirect
Sold at will
$87.07K 1,149 at 75.78
19.4%
Not planned
16 Jan 2026
Swayze Eric EVP Research · indirect
Sold at will
$3.72K 49 at 75.97
13.4%
Not planned
16 Oct 2025
Swayze Eric EVP Research · indirect
Sold at will
$3.90K 53 at 73.62
17.2%
Not planned
Showing 1–21 of 21.